Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Inks China Marketing Agreement

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews said today that it has reached a term sheet agreement with GeneDiagnostics for the marketing of its colorectal cancer risk test in parts of China.

Toronto-based GeneNews said that it expects to finalize a formal marketing partnership agreement with the Chinese firm before the end of its current fiscal quarter.

The agreement would give GeneDiagnostics non-exclusive rights to market the ColonSentry blood-based test, which uses biomarkers to determine a person's current risk for colorectal cancer, in Shanghai and in the provinces of Zhejiang and Jiangsu. These regions include a combined total of more than 38 million men and women aged 50 or older.

"The engagement of additional partners to establish a global ColonSentry marketing and distribution network is a key objective for GeneNews in 2010 and the signing of this binding term sheet with GeneDiagnostics is an important step towards achieving that goal," GeneNews President and COO Gailina Liew said in a statement.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.